Articles
01.03.2022
China's most recent NRDL update

In December 2021, China once again updated its National Reimbursed Drugs List (NRDL).

Read more
Insider Insights
01.02.2022
Committee recommends rejecting Rx to non-Rx reques

The committee’s recommendations are forwarded to the Federal Ministry of Health for consideration.

Read more
Articles
16.12.2020
New PMPRB guidelines in Canada

The Patented Medicine Prices Review Board (PMPRB) has a mandate to ensure that patented medicines ar...

Read more
Articles
05.06.2017
New parallel consultation process

A one stop shop for joint advice between EMA, EUnetHTA and health technology assessment bodies - the...

Read more
News
19.02.2015
Should the UK have a cost per QALY threshold

Should the UK have a cost per QALY threshold

Read more
Newer

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch